Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time.
A newly developed biophotonic system makes it possible to detect, in a non-invasive way and with a very small sample of blood, allergies to antibiotics in less than an hour.
Q-Sera has developed a blood collection tube which rapidly produces high-quality serum for testing. The secret to the company's success? Proteins sourced from the venom of the Australian Coastal Taipan.
Sysmex recently launched the UF-5000 flow cytometry system to measure the formed elements in urine samples.
QIAGEN's Investigator kits rapidly generate DNA profiles from blood, buccal swabs and forensic stains.
A Phase 1 clinical trial has gone seriously awry, with one volunteer now dead and others with serious, possibly irreversible, neurological damage.
The Diatron Group has introduced the Abacus Vet5 five-part differential veterinary haematology analyser and the Diatron Aquila three-part differential human haematology analyser.
Trajan Scientific and Medical has announced the hemaPEN blood collection and storage device. Harnessing the benefits of dried blood spot (DBS) sampling in a portable format, hemaPEN offers precision blood sampling with the click of a button via its familiar pen design.
The spread of bowel cancer can be stopped by targeting dormant bowel cancer cells before they form secondary tumours.
Disease, diabetes and endocrinology are the central focuses at the AACB's 2015 conference, which has the major clinical theme of 'Partnerships in testing'.
In line with the increased focus on the end uses of cannabis, including medicinal use, Southern Cross University is increasing its involvement in cannabis genetics and chemistry research.
Researchers from Clemson University have developed a new urine testing method that is said to reduce costs, achieve faster results, lower the volume of fluid needed and remove the need for invasive blood tests.
Research recently conducted at the Australian National University by Dr Peter Collignon et al has shown there is a higher correlation between government corruption and antimicrobial drug resistance than there is between the incidence of drug usage and other commonly assumed factors.
Targeted treatments based on whole genome sequencing and the time taken for conventional trials in the face of emergencies like the current Ebola outbreak are presenting new challenges to clinical trial designers.
EKF Diagnostics has introduced a diabetic biomarker test that provides a 2- to 3-week indicator of average blood glucose. The Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor test closes the information gap between daily blood glucose testing and the 2- to 3-month HbA1c reading.